Experimental design. by Xueyan Lin (448667)

“…The MHE model rats were given subcutaneous injections of 3 mL/kg of CCl4 solution (a mixture of CCl₄ and olive oil at a ratio of 1:1 v/v) twice a week and were fed 5% alcohol in drinking water for 9 consecutive weeks. …”

Calculation of chl-a anomalies from <i>in situ</i> analog chl-a values. by Benjamin M. Kraemer (7526225)

DataSheet_1_Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy.docx by Saeid Najafi-Fard (13719727)

“…Objective<p>Several therapies with immune-modulatory functions have been proposed to reduce the overwhelmed inflammation associated with COVID-19. Here we investigated the impact of IL-10 in COVID-19, through the ex-vivo assessment of the effects of exogenous IL-10 on SARS-CoV-2-specific-response using a whole-blood platform.…”

DataSheet_2_IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthc... by Bram Decru (12877073)

“…</p>Methods<p>We measured IgG anti-S and surrogate neutralizing antibody kinetics against Wild Type (WT) and 4 Variants of Concern (VOC) in health care workers (HCW) 3 and 10 months after natural infection (“infection”, n=83) or vaccination (2 doses of BNT162b2) with (“hybrid immunity”, n=17) or without prior SARS-CoV-2 infection (“vaccination”, n=97).…”

DataSheet_1_IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthc... by Bram Decru (12877073)

“…</p>Methods<p>We measured IgG anti-S and surrogate neutralizing antibody kinetics against Wild Type (WT) and 4 Variants of Concern (VOC) in health care workers (HCW) 3 and 10 months after natural infection (“infection”, n=83) or vaccination (2 doses of BNT162b2) with (“hybrid immunity”, n=17) or without prior SARS-CoV-2 infection (“vaccination”, n=97).…”

DataSheet_2_IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthc... by Bram Decru (12877073)

“…</p>Methods<p>We measured IgG anti-S and surrogate neutralizing antibody kinetics against Wild Type (WT) and 4 Variants of Concern (VOC) in health care workers (HCW) 3 and 10 months after natural infection (“infection”, n=83) or vaccination (2 doses of BNT162b2) with (“hybrid immunity”, n=17) or without prior SARS-CoV-2 infection (“vaccination”, n=97).…”

DataSheet_1_IgG Anti-Spike Antibodies and Surrogate Neutralizing Antibody Levels Decline Faster 3 to 10 Months After BNT162b2 Vaccination Than After SARS-CoV-2 Infection in Healthc... by Bram Decru (12877073)

“…</p>Methods<p>We measured IgG anti-S and surrogate neutralizing antibody kinetics against Wild Type (WT) and 4 Variants of Concern (VOC) in health care workers (HCW) 3 and 10 months after natural infection (“infection”, n=83) or vaccination (2 doses of BNT162b2) with (“hybrid immunity”, n=17) or without prior SARS-CoV-2 infection (“vaccination”, n=97).…”

Designing Reaction Coordinate for Ion-Induced Pore-Assisted Mechanism of Halide Ions Permeation through Lipid Bilayer by Umbrella Sampling by Anjana V. Mathath (17552017)

Glucocorticoid augmentation of prolonged exposure therapy: rationale and case report by Rachel Yehuda (6475829)

Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively... by Panchanan Maiti (1459852)

“…In this study, we compared single and combination (1:5) treatment of SLCP (20 μM) and berberine (100 μM) on measures of cell viability, cell death markers, levels of c-Myc and p53, along with biomarkers of the PI3K/Akt/mTOR pathways after 24–48 h of incubation. …”

Stability of Plasmonic Mg-MgO Core–Shell Nanoparticles in Gas-Phase Oxidative Environments by Vladimir Lomonosov (15213945)

“…Furthermore, we show that the reactivity of Mg-MgO nanoplates with water vapor (3.5 vol % in N₂) decreases with temperature, with no oxidation of the Mg core detected from 200 to 400 °C. …”

Stability of Plasmonic Mg-MgO Core–Shell Nanoparticles in Gas-Phase Oxidative Environments by Vladimir Lomonosov (15213945)

“…Furthermore, we show that the reactivity of Mg-MgO nanoplates with water vapor (3.5 vol % in N₂) decreases with temperature, with no oxidation of the Mg core detected from 200 to 400 °C. …”

Stability of Plasmonic Mg-MgO Core–Shell Nanoparticles in Gas-Phase Oxidative Environments by Vladimir Lomonosov (15213945)

“…Furthermore, we show that the reactivity of Mg-MgO nanoplates with water vapor (3.5 vol % in N₂) decreases with temperature, with no oxidation of the Mg core detected from 200 to 400 °C. …”

Evaluation and prediction of fish aesthetic values. by Juliette Langlois (12822131)

Demographic characteristics of participants. by David Kwame Kumador (20818068)

“…<div><p>Purpose</p><p>The present study examined mothers’ experiences with preterm infants in Accra, Ghana, at a time when the COVID-19 pandemic, existing poverty, and global economic depressions severely challenged access to communal, familial, and individual resources. We argue that, in a family crisis, contextual and external institutional resources, such as access to quality healthcare resources, play crucial roles in mothers’ risk exposure and adaptation.…”

Fig 1 - by Ruud F. W. Franssen (12484599)

DataSheet_1_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-... by Rafaella F. Q. Grenfell (12841457)

“…Background<p>Effective and safe vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are critical to controlling the COVID-19 pandemic and will remain the most important tool in limiting the spread of the virus long after the pandemic is over.…”

Table_3_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001)... by Rafaella F. Q. Grenfell (12841457)

“…Background<p>Effective and safe vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are critical to controlling the COVID-19 pandemic and will remain the most important tool in limiting the spread of the virus long after the pandemic is over.…”

Table_2_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001)... by Rafaella F. Q. Grenfell (12841457)

“…Background<p>Effective and safe vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are critical to controlling the COVID-19 pandemic and will remain the most important tool in limiting the spread of the virus long after the pandemic is over.…”

Table_4_Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001)... by Rafaella F. Q. Grenfell (12841457)

“…Background<p>Effective and safe vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are critical to controlling the COVID-19 pandemic and will remain the most important tool in limiting the spread of the virus long after the pandemic is over.…”